Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-9-10
|
pubmed:abstractText |
This study was undertaken to evaluate the frequency and prognostic significance of p53 protein accumulation in uterine sarcomas. Immunostaining for p53 protein was performed on formalin-fixed, paraffin-embedded sections from 158 patients with verified uterine sarcomas using monoclonal p53 antibody (DO-1). Antigen retrieval was performed with microwave oven technique. Nuclear p53 protein accumulation was demonstrated in 45% of the cases, more often in carcinosarcomas (73%) than in leiomyosarcomas (38%) and endometrial stromal sarcomas (27%). A significant correlation was found between p53 protein accumulation and malignancy grade (P = 0.003), mitotic count (P = 0.007), and DNA ploidy (P = 0.007), but not to FIGO stage (P = 0.6). The 5-year survival was not influenced by level of p53 protein accumulation. In Cox multivariate analysis, free resection margins at primary surgery (P < 0.0001), tumor diameter (P = 0.002), malignancy grade (P = 0.0004), and age at diagnosis (P = 0.0001) were found to be of independent prognostic significance while p53 protein accumulation had no significance (P = 0.022). Our results indicate that p53 alterations may play an important role in the carcinogenesis of uterine sarcomas, but in our study p53 protein accumulation had no impact on prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0090-8258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9698472-Adult,
pubmed-meshheading:9698472-Aged,
pubmed-meshheading:9698472-Aged, 80 and over,
pubmed-meshheading:9698472-Female,
pubmed-meshheading:9698472-Humans,
pubmed-meshheading:9698472-Immunohistochemistry,
pubmed-meshheading:9698472-Middle Aged,
pubmed-meshheading:9698472-Prognosis,
pubmed-meshheading:9698472-Sarcoma,
pubmed-meshheading:9698472-Survival Rate,
pubmed-meshheading:9698472-Tumor Suppressor Protein p53,
pubmed-meshheading:9698472-Uterine Neoplasms
|
pubmed:year |
1998
|
pubmed:articleTitle |
Immunohistochemical analysis of p53 protein in uterine sarcomas.
|
pubmed:affiliation |
Department of Gynecologic Oncology and Pathology, Norwegian Radium Hospital, University of Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|